Journals / Turkish Journal of Medical Sciences / 2015 / Cilt: 45 - Sayı: 4

Evaluation of GCF MMP-1, MMP-8, TGF-β1, PDGF-AB, and VEGF levels in periodontally healthy smokers

Pages
850–856
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Since increased levels of these molecules are involved in periodontal breakdown, our findings mayemphasize the importance for maintenance of periodontal health in smokers.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: The effect of smoking on inflammatory biomarkers in gingival crevicular fluid (GCF) is well established in thepresence of periodontal inflammation.
📊
Key Findings & Data:The aim of this study was to investigate GCF levels of MMP-1, MMP- 8, transforming growth factor (TGF)-β1, platelet-derived growth factor (PDGF)-AB, and vascular endothelial growth factor (VEGF) insmoking versus nonsmoking periodontally healthy subjects.
💡
Conclusion & Impact:Since increased levels of these molecules are involved in periodontal breakdown, our findings mayemphasize the importance for maintenance of periodontal health in smokers.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: The effect of smoking on inflammatory biomarkers in gingival crevicular fluid (GCF) is well established in thepresence of periodontal inflammation. However, it is not clear if smoking has an influence on matrix metalloproteinase (MMP) andgrowth factor levels in the GCF of periodontally healthy subjects. The aim of this study was to investigate GCF levels of MMP-1, MMP- 8, transforming growth factor (TGF)-β1, platelet-derived growth factor (PDGF)-AB, and vascular endothelial growth factor (VEGF) insmoking versus nonsmoking periodontally healthy subjects. Materials and methods: Thirty-two periodontally healthy subjects were included in this study. Probing depths, bleeding on probing,and plaque index was assessed. GCF levels of MMP-1, MMP-8, TGF-β1, PDGF-AB, and VEGF were analyzed by enzyme-linkedimmunosorbent assay.Results: No significant differences were observed in the distribution of demographic data between study groups. GCF total amount ofPDGF-AB was significantly lower in smokers compared to nonsmokers (P = 0.014). Total amount of GCF MMP-1, MMP-8, TGF-β1,and VEGF levels were similar in both study groups (P = 0.022). Conclusion: Smoking has the effect of decreasing GCF PDGF-AB while it does not affect GCF MMP-1, MMP-8, TGF-β1, and VEGFin periodontally healthy subjects. Since increased levels of these molecules are involved in periodontal breakdown, our findings mayemphasize the importance for maintenance of periodontal health in smokers.

🔖

Cite This Article

ATMACA, H., ATİLLA, F. G., TÜRKOĞLU, H. O., EREN, G. (2022). Evaluation of GCF MMP-1, MMP-8, TGF-β1, PDGF-AB, and VEGF levels in periodontally healthy smokers. Turkish Journal of Medical Sciences, Cilt: 45 - Sayı: 4, 850–856. https://ajindex.com/articles/610928

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Cesar Neto JB, Ros EF, Pannuti CM, Romito GA. Smoking and periodontal tissues: a review. Braz Oral Res 2012; 26: 25–31
  2. Javed F, Al-Askar M, Samaranayake LP, Al-Hezaimi K. Periodontal disease in habitual cigarette smokers and nonsmokers with and without prediabetes. Am J Med Sci 2013; 345: 94–98
  3. Petrovic M, Kesic L, Obradovic R, Savic Z, Mihailovic D, Obradovic I, Avdic-Saracevic M, Janjic-Trickovic O, Janjic M. Comparative analysis of smoking influence on periodontal tissue in subjects with periodontal disease. Mater Sociomed 2013; 25: 196–198
  4. Bergström J. Cigarette smoking as risk factor in chronic periodontal disease. Community Dent Oral Epidemiol 1989; 17: 245–247
  5. Güntsch A, Erler M, Preshaw PM, Sigusch BW, Klinger G, Glockmann E. Effect of smoking on crevicular polymorphonuclear neutrophil function in periodontally healthy subjects. J Periodontal Res 2006; 41: 184–188
  6. Pabst MJ, Pabst KM, Collier JA, Coleman TC, Lemons-Prince ML, Godat MS, Waring MB, Babu JP. Inhibition of neutrophil and monocyte defensive functions by nicotine. J Periodontol 1995; 66: 1047–1055
  7. Giannopoulou C, Kamma JJ, Mombelli A. Effect of inflammation, smoking and stress on gingival crevicular fluid cytokine level. J Clin Periodontol 2003; 30: 145–153
  8. Bergström J. Tobacco smoking and risk for periodontal disease. J Clin Periodontol 2003; 30: 107–113
  9. Martinez-Canut P, Lorca A, Magàn R. Smoking and periodontal disease severity. J Clin Peridontondol 1995; 22: 743–749
  10. Albandar JM. Global risk factors and risk indicators for periodontal diseases. Periodontol 2000 2002; 29: 177–206
  11. Kaldahl WB, Johnson GK, Patil KD, Kalkwarf KL. Levels of cigarette consumption and response to periodontal therapy. J Periodontol 1996; 67: 675–681
  12. Johannsen A, Susin C, Gustafsson A. Smoking and inflammation: evidence for a synergistic role in chronic disease. Periodontol 2000 2014; 64: 111–126
  13. Champagne CM, Buchanan W, Reddy MS, Preisser JS, Beck JD, Offenbacher S. Potential for gingival crevice fluid measures as predictors of risk for periodontal diseases. Periodontol 2000 2003; 31: 167–180
  14. Sorsa T, Mäntylä P, Rönkä H, Kallio P, Kallis GB, Lundqvist C, Kinane DF, Salo T, Golub LM, Teronen O et al. Scientific basis of a matrix metalloproteinase-8 specific chair-side test for monitoring periodontal and peri-implant health and disease. Ann NY Acad Sci 1999; 878: 130–140
  15. Reynolds JJ, Meikle MC. Mechanisms of connective tissue matrix destruction in